Immune subtypes, containing wound healing (C1), INF-gamma dominant (C2), inflammatory (C3), lymphocyte depleted (C4), immunologically quiet (C5), and TGF-β dominant (C6) are closely linked to overall survival and progression-free interval of cancer patients. The gene discussed is TGFB1; the disease is cancer.